Draft RAR concludes that glyphosate has no endocrine disrupting properties
The RMS have re-evaluated glyphosate for its potential to be an endocrine disruptor.
The conclusion from the draft weight of evidence assessment (section 2.10) is in concordance with the conclusions from the 2017 weight of evidence assessment published by EFSA and the USEPA weight of evidence assessment published in 2015 – both concluding glyphosate is not an endocrine disruptor though the estrogenic, androgenic, thyroid, and steroidogenic pathways.
If you are interested to review and comment the draft endocrine assessment for glyphosate additional background information can be found here.
The full Position Paper can be accessed via this link.